{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:23:26Z","timestamp":1777983806366,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bone.2019.115157","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:25:56Z","timestamp":1573691156000},"page":"115157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Denosumab failure associated with escape from suppression of bone resorption"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8419-7987","authenticated-orcid":false,"given":"Alicia R.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ie-Wen","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bone.2019.115157_bb0005","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2019.115157_bb0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.115157_bb0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2018.10.001","article-title":"Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment","volume":"120","author":"Tsourdi","year":"2019","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2019.115157_bb0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.115157_bb0025","series-title":"Escape From Denosumab Mediated Suppression of Bone Resorption in Primary Biliary Cirrhosis","author":"Vedere","year":"2017"},{"issue":"1","key":"10.1016\/j.bone.2019.115157_bb0030","first-page":"68","article-title":"Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis","volume":"30","author":"Allanore","year":"2003","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.bone.2019.115157_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066991","article-title":"Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study","volume":"8","author":"Atteritano","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bone.2019.115157_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00223-002-2127-x","article-title":"Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification","volume":"73","author":"Murphy","year":"2003","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2019.115157_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-4637.2001.01028.x","article-title":"Transdermal fentanyl: little absorption in two patients with systemic sclerosis?","volume":"2","author":"Karst","year":"2001","journal-title":"Pain Med."},{"issue":"1","key":"10.1016\/j.bone.2019.115157_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1270-8","article-title":"Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis","volume":"19","author":"Sulli","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.bone.2019.115157_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.bone.2019.115157_bb0060","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.3899\/jrheum.080192","article-title":"Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis","volume":"35","author":"Dovio","year":"2008","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.bone.2019.115157_bb0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/14397595.2018.1500736","article-title":"Osteoprotegrin interacts with biomarkers and cytokines that have roles in osteoporosis, skin fibrosis, and vasculopathy in systemic sclerosis: a potential multifaceted relationship between OPG\/RANKL\/TRAIL and Wnt inhibitors","volume":"29","author":"Taylan","year":"2019","journal-title":"Mod. Rheumatol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821930451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821930451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:44:54Z","timestamp":1757612694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821930451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":13,"alternative-id":["S875632821930451X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.115157","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab failure associated with escape from suppression of bone resorption","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.115157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115157"}}